Opportunity Radar

← Back to search

Contract

Olopatadine HCL 0.1% Ophthalmic Solution

View on SAM.gov ↗ Sign in to save

Type
Contract
Notice type
Award Notice
Agency
DEPT OF DEFENSE
Sub-agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Solicitation #
SPE2D222R0117
Posted
Jan 21, 2025
Archive date
Feb 15, 2028
NAICS
325412
PSC
6505
Place of performance
Ontario, Canada, CAN
Award amount
$17,621,453
Awardee
GOLDEN STATE MEDICAL SUPPLY INC Camarillo CA 93012 USA
Contact
Kyle Lewicki · kyle.lewicki@dla.mil · 2157373696
Source
SAM.gov

Description

Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract. Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle

Similar open opportunities